Depomed Licenses Acuform® Patents to Janssen Pharmaceuticals, Inc. MENLO PARK, Calif., Aug. 27, 2012 /PRNewswire/ -- Depomed, Inc. (Nasdaq: DEPO) today announced that Janssen Pharmaceuticals, Inc., ...

ST. LOUIS & MENLO PARK, Calif., Nov 24, 2008 (BUSINESS WIRE) -- Covidien and Depomed, today announced that Covidien has licensed worldwide rights from Depomed to utilize Depomed's AcuForm(TM) gastric ...

MENLO PARK, Calif., Aug 5, 2010 (GlobeNewswire via COMTEX) -- Depomed, Inc. (Nasdaq:DEPO) today announced that Janssen Pharmaceutica N.V. has licensed worldwide rights to Depomed's Acuform(R) gastric ...

MENLO PARK, Calif. Depomed has won summary judgment in a U.S. District Court in a patent infringement case against IVAX, according to published reports. The case involved two patents related to the ...

Up to $64M in milestone payments could be realized. Covidien has licensed worldwide rights to utilize Depomed’s AcuForm™ gastric retentive drug delivery technology for the exclusive development of ...

Depomed (DEPO) and Biovail Corp (BVF) announce that the cos have entered into an agreement that provides Biovail with access to DEPO's proprietary AcuForm drug delivery technology for the development ...

MENLO PARK, Calif., Jan. 18, 2011 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today announced that it will engage in a mediation process with Abbott Products, Inc., regarding Abbott's ...

MENLO PARK, Calif., Aug. 27, 2012 /PRNewswire/ -- Depomed, Inc. (Nasdaq:DEPO) today announced that Janssen Pharmaceuticals, Inc., has licensed rights to Depomed's Acuform gastric retentive drug ...